Jodetten

Potassium Iodide, the active ingredient in Jodetten, is a thyroid blocking agent presented as an oral preparation for oral use. It is employed to saturate the thyroid gland with stable iodine, thereby reducing the uptake of radioactive iodine during nuclear emergencies and providing iodine supplementation when needed.

GNH USA supplies Jodetten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for cross‑border distribution. Customers benefit from reliable supply chains and on‑time delivery across EU and global markets.

Jodetten (potassium iodide) acts as a thyroid blocking agent to prevent radioactive iodine uptake.

- Radiation emergency prophylaxis: Reduces thyroid absorption of radioactive iodine, lowering risk of radiation‑induced thyroid cancer. - Thyroid protection during nuclear incidents: Provides stable iodine to saturate the gland, shielding it from harmful isotopes. - Iodine supplementation: Supplies essential iodine for individuals with dietary deficiency or increased physiological demand.

Potassium iodide is generally well tolerated, but some individuals may experience adverse reactions.

Common Side Effects: - Nausea or upset stomach: mild gastrointestinal discomfort after oral intake. - Metallic taste: transient metallic sensation in the mouth. - Salivary gland swelling: mild enlargement of salivary glands. - Skin rash: mild erythema or itching at the site of contact. - Vomiting: occasional episodes following dose.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Thyrotoxicosis: excessive thyroid hormone release in susceptible individuals. - Hyperkalemia: elevated blood potassium levels, potentially causing cardiac rhythm disturbances. - Severe abdominal pain: may indicate acute gastritis. - Anaphylactic shock: life‑threatening systemic allergic response. - Cardiac arrhythmia: irregular heart rhythm due to electrolyte imbalance.

When using potassium iodide, several precautions should be observed to ensure safety and effectiveness.

- Assess thyroid status: confirm normal thyroid function before administration. - Evaluate iodine sensitivity: avoid use in individuals with known iodine allergy. - Consider age and dosage: children and pregnant persons require special medical assessment. - Monitor for adverse reactions: watch for signs of hypersensitivity or thyroid dysfunction. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Potassium iodide may interact with certain medications, altering its efficacy or safety.

Major Interactions (Avoid): - Lithium: concurrent use can exacerbate lithium toxicity and affect thyroid function. - Antithyroid drugs (e.g., propylthiouracil, methimazole): may reduce the protective effect of potassium iodide. - Radioactive iodine therapy: potassium iodide can diminish therapeutic uptake of radioactive iodine.

Moderate Interactions (Monitor Closely): - Diuretics (especially potassium‑sparing): may increase risk of hyperkalemia. - ACE inhibitors or ARBs: monitor serum potassium levels when combined. - Amiodarone: both provide iodine and can affect thyroid hormone balance.